This page shows the latest Tofersen news and features for those working in and with pharma, biotech and healthcare.
There’s still plenty in the neuroscience pipeline however, including tofersen for amyotrophic lateral sclerosis (ALS) which stems from an alliance with antisense specialist Ionis and is due for a phase
Hope for subset of patients with wasting disease. Biogen has revealed promising preliminary data for tofersen, a potential treatment for the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS). ... Tofersen is just one of seven candidates
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...